1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
CAMP4 Therapeutics Corporation

CAMP4 Therapeutics Corporation

CAMP
CAMP4 Therapeutics CorporationUS flagNASDAQ Global Market
4.17
USD
+0.19
- -
88.57MMarket Cap

Income Statement (USD)

APIChat
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
- -
- -
1
3
+ Sales & Services Revenue
- -
- -
1
3
- Cost of Revenue
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
+ Other Operating Income
- -
- -
-1
-3
- Operating Expenses
45
52
54
56
+ Selling, General & Admin
10
12
15
17
+ Research & Development
35
41
39
38
+ Other Operating Expense
- -
- -
- -
- -
Operating Income (Loss)
-45
-52
-53
-52
- Non-Operating (Income) Loss
-1
-3
-1
28
+ Interest Expense, Net
-1
-3
-1
-2
+ Interest Expense
- -
- -
- -
- -
- Interest Income
1
3
1
2
+ Other Non-Op (Income) Loss
- -
- -
- -
31
Pretax Income
-44
-49
-52
-80
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
Income (Loss) from Cont Ops
-44
-49
-52
-80
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
Income (Loss) Incl. MI
-44
-49
-52
-80
- Minority Interest
- -
- -
- -
- -
Net Income, GAAP
-44
-49
-52
-80
- Preferred Dividends
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-44
-49
-52
-80
EBIT
-45
-52
-53
-52
EBITDA
-44
-50
-51
-50
EBITDA Margin (%)
- -
-14,343.14
-7,882.21
-1,441.45
EBITA
-45
-52
-53
-52
Gross Margin (%)
- -
100
100
100
Operating Margin (%)
- -
-14,822.57
-8,142.33
-1,488.31
Profit Margin (%)
- -
-14,083.14
-7,943.4
-2,298.54
Sales per Employee
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
Depreciation Expense
1
2
2
2
Basic Weighted Avg Shares
12
12
5
- -
Basic EPS, GAAP
-3.64
-4.07
-11.04
- -
Basic EPS from Cont Ops
-3.64
-4.07
-11.04
- -
Diluted Weighted Avg Shares
12
12
5
- -
Diluted EPS, GAAP
-3.64
-4.07
-11.04
- -
Diluted EPS from Cont Ops
-3.64
-4.07
-11.04
- -

Balance Sheet (USD)

APIChat
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
84
40
66
114
+ Cash, Cash Equivalents & STI
83
38
64
110
+ Cash & Cash Equivalents
83
38
64
110
+ ST Investments
- -
- -
- -
- -
+ Accounts & Notes Receiv
1
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
+ Other Receivable, Net
1
- -
- -
- -
+ Inventories
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
+ Other ST Assets
1
1
2
4
+ Misc ST Assets
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
Total Noncurrent Assets
18
15
12
4
+ Property, Plant & Equip, Net
17
13
10
3
+ Property, Plant & Equip
20
18
17
11
- Accumulated Depreciation
3
5
6
8
+ LT Investments & Receivables
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
+ Other LT Assets
1
2
2
1
+ Total Intangible Assets
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
+ Misc LT Assets
1
2
2
1
Total Assets
103
55
78
118
+ Payables & Accruals
4
2
2
3
+ Accounts Payable
2
1
1
- -
+ Accrued Taxes
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
+ Other Payables & Accruals
2
1
1
3
+ ST Debt
2
3
3
- -
+ ST Borrowings
- -
- -
- -
- -
+ ST Finance Leases
2
3
3
- -
+ Other ST Liabilities
2
2
4
12
+ Deferred Revenue
- -
- -
- -
9
+ Derivatives & Hedging
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Misc ST Liabilities
2
2
4
3
Total Current Liabilities
8
8
10
16
+ LT Debt
10
9
5
2
+ LT Borrowings
- -
- -
- -
- -
+ LT Finance Leases
10
9
5
2
+ Other LT Liabilities
162
162
- -
53
+ Accrued Liabilities
- -
- -
- -
8
+ Pension Liabilities
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Misc LT Liabilities
162
162
- -
45
Total Noncurrent Liabilities
172
171
6
55
Total Liabilities
180
179
15
70
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
+ Share Capital & APIC
33
36
275
340
+ Common Stock
- -
- -
- -
- -
+ Additional Paid in Capital
33
36
275
340
- Treasury Stock
- -
- -
- -
- -
+ Retained Earnings
-111
-160
-212
-292
+ Other Equity
- -
- -
- -
- -
Equity Before Minority Interest
-78
-124
63
48
+ Minority/Non Controlling Interest
- -
- -
- -
- -
Total Equity
-78
-124
63
48
Total Liabilities & Equity
103
55
78
118
Shares Outstanding
20
20
20
52
Number of Employees
- -
- -
- -
- -
Capital Leases - Total
12
12
8
2
Net Debt
-83
-38
-64
-110
Net Debt to Equity
107.3
31.02
-101.42
-229.58
Tangible Common Equity Ratio
-75.6
-225.18
80.64
40.49
Current Ratio
10.62
5.13
6.92
7.35
Cash Conversion Cycle
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-44
-49
-52
-80
+ Depreciation & Amortization
1
2
2
2
+ Non-Cash Items
3
5
6
36
+ Stock-Based Compensation
1
3
4
4
+ Deferred Income Taxes
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
+ Other Non-Cash Adj
2
2
2
32
+ Chg in Non-Cash Work Cap
2
-1
-1
13
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
-1
- -
-1
-1
+ Inc (Dec) in Accts Payable
3
-1
2
- -
+ Inc (Dec) in Other
-1
- -
-2
14
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Operating Activities
-39
-44
-46
-30
+ Change in Fixed & Intang
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
+ Acq of Fixed & Intang
-4
-1
- -
- -
+ Acq of Fixed Prod Assets
-4
-1
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
76
58
+ Increase in Capital Stock
- -
- -
76
58
+ Decrease in Capital Stock
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Investing Activities
-4
-1
- -
- -
+ Dividends Paid
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
+ Other Financing Activities
100
1
-4
18
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Financing Activities
100
- -
72
76
Effect of Foreign Exchange Rates
- -
- -
- -
- -
Net Changes in Cash
58
-45
26
46
EBITDA
-44
-50
-51
-50
EBITDA Margin (%)
- -
-14,343.14
-7,882.21
-1,441.45
Free Cash Flow
-43
-45
-46
-30
Net Cash Paid for Acquisitions
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-45
-46
-30
Free Cash Flow per Basic Share
-3.51
-3.7
-9.81
- -
Price/Free Cash Flow
-36.19
-1.61
-0.54
- -
Cash Flow to Net Income
0.87
0.9
0.88
0.37
Capital Expenditures
-4
-1
- -
- -